Paper6252923
Immunization against primary, transplanted and spontaneous murine leukaemia using a live Moloney sarcoma virus vaccine.
Mayer AM and 2 others. Br J Cancer, 1980. Cited by 2 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Download JSON
Cite this record
ConductScience Library. Immunization against primary, transplanted and spontaneous murine leukaemia using a live Moloney sarcoma virus vaccine. Papers, record 6252923. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6252923
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immunization against primary, transplanted and spontaneous murine leukaemia using a live Moloney sarcoma virus vaccine.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukemia, Experimental | Major topic |
| Moloney murine leukemia virus | Major topic |
| Sarcoma Viruses, Murine | Major topic |
| Viral Vaccines | Major topic |
| Animals | |
| Female | |
| Immunization | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Neoplasm Transplantation | |
| Transplantation, Homologous |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11,515,450 | Pathologic and virologic studies of tumors induced in mice by two strains of murine sarcoma virus. | J Natl Cancer Inst | 1970 | https://conductscience.org/library/papers/11515450 | PubMed |
| 2 | 5,923,170 | Induction of resistance against the transplantation of leukemias induced by Rauscher virus. | Cancer Res | 1966 | https://conductscience.org/library/papers/5923170 | PubMed |
| 3 | 5,927,754 | Pathogenesis of a virus-induced rhabdomyosarcoma in mice. | J Natl Cancer Inst | 1966 | https://conductscience.org/library/papers/5927754 | PubMed |
| 4 | 4,290,556 | Antigenicity of a virus-induced murine sarcoma (Moloney). | Cancer Res | 1967 | https://conductscience.org/library/papers/4290556 | PubMed |
| 5 | 6,027,002 | Induced resistance of mice to a lymphoid strain of leukemia virus (Moloney). | Cancer | 1967 | https://conductscience.org/library/papers/6027002 | PubMed |
| 6 | 6,028,555 | Inhibition of solid tumor formation by prior immunization with formalized neoplastic spleen extracts. | Proc Soc Exp Biol Med | 1967 | https://conductscience.org/library/papers/6028555 | PubMed |
| 7 | 5,582,284 | Neutralization of the oncogenicity of Moloney sarcoma virus and Moloney leukemia virus by anti-Gross serum. | Int J Cancer | 1967 | https://conductscience.org/library/papers/5582284 | PubMed |
| 8 | 4,867,923 | Cross-resistance to the transplantation of syngeneic Friend, Moloney, and Rauscher virus-induced tumors. | Cancer Res | 1968 | https://conductscience.org/library/papers/4867923 | PubMed |
| 9 | 5,658,439 | Increased oncogenicity of the murine sarcoma virus (Moloney) by co-infection with murine leukemia viruses. | Cancer Res | 1968 | https://conductscience.org/library/papers/5658439 | PubMed |
| 10 | 4,876,979 | Immunologic, virologic, and pathologic studies of regression of autochthonous Moloney sarcoma virus-induced tumors in mice. | Cancer Res | 1968 | https://conductscience.org/library/papers/4876979 | PubMed |
| 11 | 5,730,264 | [Murine leukemia]. | Medicina (B Aires) | 1968 | https://conductscience.org/library/papers/5730264 | PubMed |
| 12 | 5,358,213 | Enhancement of murine sarcoma virus (Moloney) infection and tumorigenesis in vivo by coinfection with Rauscher leukemia virus. | Cancer Res | 1969 | https://conductscience.org/library/papers/5358213 | PubMed |
| 13 | 4,333,859 | The murine sarcoma virus (MSV). | Int Rev Exp Pathol | 1971 | https://conductscience.org/library/papers/4333859 | PubMed |
| 14 | 4,748,428 | Senescent loss of resistance to murine sarcoma virus (Moloney) in the mouse. | Cancer Res | 1973 | https://conductscience.org/library/papers/4748428 | PubMed |
| 15 | 4,757,083 | [Oncogenicity of immune lymphoid cells from MSV-M regressors (author's transl)]. | Tumori | 1973 | https://conductscience.org/library/papers/4757083 | PubMed |
| 16 | 4,762,933 | In vitro cytotoxicity studies of murine sarcoma virus-induced immunity in mice. | J Natl Cancer Inst | 1973 | https://conductscience.org/library/papers/4762933 | PubMed |
| 17 | 4,594,340 | The immune response to primary Moloney sarcoma virus tumors in BALB-c mice: cellular and humoral activity of long-term regressors. | Int J Cancer | 1974 | https://conductscience.org/library/papers/4594340 | PubMed |
| 18 | 4,608,945 | Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes. | J Exp Med | 1974 | https://conductscience.org/library/papers/4608945 | PubMed |
| 19 | 1,136,142 | Properties of mouse leukemia viruses. IX. Active and passive immunization of mice against Friend leukemia with isolated viral GP71 glycoprotein and its corresponding antiserum. | Virology | 1975 | https://conductscience.org/library/papers/1136142 | PubMed |
| 20 | 169,829 | In vivo interactions between murine leukemia and sarcoma viruses. | Bibl Haematol | 1975 | https://conductscience.org/library/papers/169829 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6252923
GET https://conductscience.org/api/papers/v1/6252923/references?page=2